Cilcare
Biotechnology Research • 
Montpellier, Occitanie, France • 51-100 Employees
Company overview
| Headquarters | 378 rue du Professeur Joseph-Blayac, Montpellier, Languedoc-Roussillon 34080, FR |
| Phone number | +3307813416 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | AI, Precision Medicine, Hearing Loss, Clinical Development, Tinnitus, Pharmaceutical Development, Pharmacology, Preclinical Development, Hearing Disorders, Glp Ototoxicology, Auditory Safety, Ear Disorders |
| Founded | 2014 |
| Employees | 51-100 |
| Socials |
Key Contacts at Cilcare
Preethi Sundaram
Independent Director, Board Of Directors
Marie Peytavy-Izard
Marketing & Communication Director
Yelyzaveta Byelyayeva
Associate Director Sales, Funding And New Partnerships
Aurore Marie
Director, Cilcare Usa & Head Of Operational Excellence
Mathieu Schue
Director Of Clinical Sciences And Operations
Susanna Malmström
Director Of Sales & Subcontracts, Esg Pilot
Francesca Rapido
Director Of Translational Research
Elodie Flaszka
Associate Director Of Planning And Ressources Management
Cilcare Email Formats
Cilcare uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@cilcare.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@cilcare.com | 50% |
{first initial}.{last name} | j.doe@cilcare.com | 46.2% |
{first initial}-{last name}.{last name} | j-doe.doe@cilcare.com | 3.8% |
About Cilcare
CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, synaptopathy, ototoxicity, sensorineural hearing loss and tinnitus. CILCARE Therapeutics has forged a portfolio of proprietary drug candidates and co-developed programs, while pioneering an unprecedented clinical approach to developing compounds targeting cochlear synaptopathy. CILCARE Auditory Analytics aims to position hearing as a key asset of preventive medicine and global healthcare monitoring. We aim to utilize patients' auditory measurements to define digital auditory signatures that will serve to characterize different forms of hearing impairments or other pathologies with precision.
Cilcare revenue & valuation
| Annual revenue | $5,389,965 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $17,300,000 |
| Total funding | $42,000,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Cilcare has 33 employees across 8 departments.
Departments
Number of employees
Cilcare Tech Stack
Discover the technologies and tools that power Cilcare's digital infrastructure, from frameworks to analytics platforms.
Video players
WordPress plugins
JavaScript frameworks
JavaScript libraries
JavaScript libraries
JavaScript libraries
UI frameworks
JavaScript libraries
Maps
Page builders
JavaScript libraries
Poland
Luxembourg
Spain
Switzerland
Frequently asked questions
4.8
40,000 users
